SHOC2 and CRAF Mediate ERK1/2 Reactivation in Mutant NRAS-mediated Resistance to RAF Inhibitor von Kaplan, Fred M., Kugel, Curtis H., Dadpey, Neda, Shao, Yongping, Abel, Ethan V., Aplin, Andrew E.

Volltext

FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma von Weiss, Michele B, Abel, Ethan V, Dadpey, Neda, Aplin, Andrew E

Volltext

Abstract A31: 14-3-3 binding sites in full-length and splice variant forms of BRAF V600E modulate the response to RAF inhibitors von Vido, Michael J., Le, Kaitlyn, Rock, Justin, Hartsough, Edward J., Dadpey, Neda, Aplin, Andrew E.

Volltext

In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors von BASILE, Kevin J, ABEL, Ethan V, DADPEY, Neda, HARTSOUGH, Edward J, FORTINA, Paolo, APLIN, Andrew E

Volltext

Abstract 3928: In vivo ERK1/2 reporting demonstrates the association and timing of ERK1/2 pathway reactivation and acquired resistance to RAF inhibitors von Basile, Kevin J., Abel, Ethan V., Dadpey, Neda, Aplin, Andrew E.

Volltext